Page last updated: 2024-11-02

pioglitazone and Essential Tremor

pioglitazone has been researched along with Essential Tremor in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Essential Tremor: A relatively common disorder characterized by a fairly specific pattern of tremors which are most prominent in the upper extremities and neck, inducing titubations of the head. The tremor is usually mild, but when severe may be disabling. An autosomal dominant pattern of inheritance may occur in some families (i.e., familial tremor). (Mov Disord 1988;13(1):5-10)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aghaei, I1
Hajali, V1
Haghani, M1
Vaziri, Z1
Moosazadeh, M1
Shabani, M1

Other Studies

1 other study available for pioglitazone and Essential Tremor

ArticleYear
Peroxisome proliferator-activated receptor-γ activation attenuates harmaline-induced cognitive impairments in rats.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2019, Volume: 59

    Topics: Animals; Behavior, Animal; Cognitive Dysfunction; Essential Tremor; Harmaline; Male; Maze Learning;

2019